Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 16 results
Filters: First Letter Of Last Name is E  [Clear All Filters]
Found 16 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

E

Erlandson KM, Wu K, Koletar SL, et al. "Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy." J. Infect. Dis.. 2017;215(6):933-937.
Erlandson KM, Taejaroenkul S, Smeaton L, et al. "A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings." Open Forum Infect Dis. 2015;2(3):ofv095.
Erlandson KM, Fiorillo SP, Cardoso SWagner, et al. "Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation." AIDS Res. Hum. Retroviruses. 2017;33(9):929-934.
Erlandson KMace, Kitch D, Tierney C, et al. "Impact of randomized antiretroviral therapy initiation on glucose metabolism." AIDS. 2014;28(10):1451-61.
Erlandson KM, Kitch D, Tierney C, et al. "Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density." AIDS. 2013;27(13):2069-79.
Erlandson KM, Kitch D, C Wester W, et al. "The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection." Clin. Infect. Dis.. 2017;65(12):2042-2049.
Erlandson KM, Fiorillo S, Masawi F, et al. "Antiretroviral initiation is associated with increased skeletal muscle area and fat content." AIDS. 2017;31(13):1831-1838.
Eron JJ, Park J-G, Haubrich R, et al. "Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy." Antimicrob. Agents Chemother.. 2009;53(6):2335-41.
Eron JJ, Bosch RJ, Bettendorf D, Petch L, Fiscus S, Frank I. "The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine." J. Acquir. Immune Defic. Syndr.. 2007;45(2):249-51.
Eshleman SH, Hudelson SE, Redd AD, et al. "Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial." J. Infect. Dis.. 2011;204(12):1918-26.
Evans SR, Simpson DM, Kitch DW, et al. "A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain." PLoS ONE. 2007;2(6):e551.
Evans SR, Ellis RJ, Chen H, et al. "Peripheral neuropathy in HIV: prevalence and risk factors." AIDS. 2011;25(7):919-28.
Evans SR, Clifford DB, Kitch DW, et al. "Simplification of the research diagnosis of HIV-associated sensory neuropathy." HIV Clin Trials. 2008;9(6):434-9.
Evans SR, Yeh T-min, Sacktor N, et al. "Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090." HIV Clin Trials. 2007;8(6):437-46.
Evans SR, Fichtenbaum CJ, Aberg JA. "Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087." HIV Clin Trials. 2007;8(1):45-52.
Evans SR, Lee AJ, Ellis RJ, et al. "HIV peripheral neuropathy progression: protection with glucose-lowering drugs?" J. Neurovirol.. 2012;18(5):428-33.